Health Care Stocks Will Continue to Lead Market Higher

Health care stocks have traditionally been viewed as defensive, but over the past 5 years the sector has been the best performer the S&P 500. Mario Minot, partner at Minotti Group Wealth Advisors, says the run in healthcare names is far from over. "The healthcare sector is really dynamic right now and there has been huge investment in the arena spurred by the Affordable Care Act," says Minotti. "The growth has been across the board because it's a broad industry that encompasses hospitals, pharmaceuticals, insurance companies and medical device players."

The Healthcare Select Sector SPDR, which owns shares of Johnson & Johnson (JNJ) and Pfizer (PFE), has returned 163% in the past 5 years, compared to a 140% gain for the second-place Consumer Discretionary SPDR and a 104% rise for the third-place Technology SPDR. When it comes to healthcare's often volatile cousin biotech, Minotti says he is not turning away from it despite its high valuation. The iShares Nasdaq Biotechnology ETF, which holds stocks like Amgen (AMGN - Get Report) and Gilead (GILD - Get Report), is up 348% in the past 5 years. Its holdings also trade for an above market multiple of 25 times trailing 12 months earnings.

Source: The Street

Related Articles:
- Dividends vs. Stock Buybacks
- 5 Lessons Learned About Investing In Dividend Growth Stocks
- 6 High-Yielding Mega-Cap Stocks
- Dividend Investors Should Focus On Stocks, Not The Market
- The Secret Ingredient of Dividend Growth Stocks